A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN.
Brachydactyly type B (BDB) is characterized by terminal deficiency of fingers and toes, which is caused by heterozygous truncating mutations in the receptor tyrosine kinase-like orphan receptor 2 (ROR2) in the majority of patients. In a subset of ROR2-negative patients with BDB, clinically defined b...
| Huvudupphovsmän: | , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
2007
|
| _version_ | 1826271731173556224 |
|---|---|
| author | Lehmann, K Seemann, P Silan, F Goecke, T Irgang, S Kjaer, K Kjaergaard, S Mahoney, M Morlot, S Reissner, C Kerr, B Wilkie, A Mundlos, S |
| author_facet | Lehmann, K Seemann, P Silan, F Goecke, T Irgang, S Kjaer, K Kjaergaard, S Mahoney, M Morlot, S Reissner, C Kerr, B Wilkie, A Mundlos, S |
| author_sort | Lehmann, K |
| collection | OXFORD |
| description | Brachydactyly type B (BDB) is characterized by terminal deficiency of fingers and toes, which is caused by heterozygous truncating mutations in the receptor tyrosine kinase-like orphan receptor 2 (ROR2) in the majority of patients. In a subset of ROR2-negative patients with BDB, clinically defined by the additional occurrence of proximal symphalangism and carpal synostosis, we identified six different point mutations (P35A, P35S, A36P, E48K, R167G, and P187S) in the bone morphogenetic protein (BMP) antagonist NOGGIN (NOG). In contrast to previously described loss-of-function mutations in NOG, which are known to cause a range of conditions associated with abnormal joint formation but without BDB, the newly identified BDB mutations do not indicate a major loss of function, as suggested by calculation of free-binding energy of the modeled NOG-GDF5 complex and functional analysis of the micromass culture system. Rather, they presumably alter NOG's ability to bind to BMPs and growth-differentiation factors (GDFs) in a subtle way, thus disturbing the intricate balance of BMP signaling. The combined features observed in this phenotypic subtype of BDB argue for a functional connection between BMP and ROR2 signaling and support previous findings of a modulating effect of ROR2 on the BMP-receptor pathway through the formation of a heteromeric complex of the receptors at the cell surface. |
| first_indexed | 2024-03-06T22:01:19Z |
| format | Journal article |
| id | oxford-uuid:4eae48a2-4ed8-41ac-acea-3bcd9d135f39 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:01:19Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:4eae48a2-4ed8-41ac-acea-3bcd9d135f392022-03-26T16:02:39ZA new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4eae48a2-4ed8-41ac-acea-3bcd9d135f39EnglishSymplectic Elements at Oxford2007Lehmann, KSeemann, PSilan, FGoecke, TIrgang, SKjaer, KKjaergaard, SMahoney, MMorlot, SReissner, CKerr, BWilkie, AMundlos, SBrachydactyly type B (BDB) is characterized by terminal deficiency of fingers and toes, which is caused by heterozygous truncating mutations in the receptor tyrosine kinase-like orphan receptor 2 (ROR2) in the majority of patients. In a subset of ROR2-negative patients with BDB, clinically defined by the additional occurrence of proximal symphalangism and carpal synostosis, we identified six different point mutations (P35A, P35S, A36P, E48K, R167G, and P187S) in the bone morphogenetic protein (BMP) antagonist NOGGIN (NOG). In contrast to previously described loss-of-function mutations in NOG, which are known to cause a range of conditions associated with abnormal joint formation but without BDB, the newly identified BDB mutations do not indicate a major loss of function, as suggested by calculation of free-binding energy of the modeled NOG-GDF5 complex and functional analysis of the micromass culture system. Rather, they presumably alter NOG's ability to bind to BMPs and growth-differentiation factors (GDFs) in a subtle way, thus disturbing the intricate balance of BMP signaling. The combined features observed in this phenotypic subtype of BDB argue for a functional connection between BMP and ROR2 signaling and support previous findings of a modulating effect of ROR2 on the BMP-receptor pathway through the formation of a heteromeric complex of the receptors at the cell surface. |
| spellingShingle | Lehmann, K Seemann, P Silan, F Goecke, T Irgang, S Kjaer, K Kjaergaard, S Mahoney, M Morlot, S Reissner, C Kerr, B Wilkie, A Mundlos, S A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. |
| title | A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. |
| title_full | A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. |
| title_fullStr | A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. |
| title_full_unstemmed | A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. |
| title_short | A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. |
| title_sort | new subtype of brachydactyly type b caused by point mutations in the bone morphogenetic protein antagonist noggin |
| work_keys_str_mv | AT lehmannk anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT seemannp anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT silanf anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT goecket anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT irgangs anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT kjaerk anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT kjaergaards anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT mahoneym anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT morlots anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT reissnerc anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT kerrb anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT wilkiea anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT mundloss anewsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT lehmannk newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT seemannp newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT silanf newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT goecket newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT irgangs newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT kjaerk newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT kjaergaards newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT mahoneym newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT morlots newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT reissnerc newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT kerrb newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT wilkiea newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin AT mundloss newsubtypeofbrachydactylytypebcausedbypointmutationsinthebonemorphogeneticproteinantagonistnoggin |